BioSpace News Archive

Curia, formerly AMRI, today announced it has entered into a definitive agreement to acquire Integrity Bio, Inc., a privately held formulation and fill-finish organization headquartered in Camarillo, California.

Certara®, a global leader in biosimulation, announced that it has appointed Nicolette D. Sherman to the position of Chief Human Resources Officer.

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), announced today that it has received approval from the Spanish Drug Agency (AEMPS) for its Clinical Trial Application (CTA) to conduct a Phase IIb clinical trial with vafidemstat in patients with schizophrenia.

Shoreline Biosciences, Inc. today announced the appointments of Boyan Litchev , M.D. as Senior Vice President and Head of Global Clinical Development.

When a doctor gives a patient antibiotics for a bacterial infection, they usually require them to finish the entire treatment, even when symptoms go away.

Cardea Bio, a Tech+Bio company that has integrated molecular biology with semiconductor electronics, today announced that Dawn Barry has joined the company’s Board of Directors.

Nascent Biotech, Inc., a biotechnology company pioneering innovative medicines to overcome difficult-to-treat cancers and viral infections, and its collaboration partner, Manhattan BioSolutions, are pleased to announce promising new preliminary preclinical results for the COVID-19 vaccine candidate now progressing under joint development by the Partners.

Hoth Therapeutics, Inc. announced today that its HT-003 group of assets has yielded positive results in an in vivo acne therapeutic model.

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced that the company has expanded patient enrollment to Canada for the final part of a Phase 2b study evaluating its EB01 drug candidate as a monotherapy for chronic Allergic Contact Dermatitis, or ACD.

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present “Rebalancing: Digital Therapeutics in a Post-Pandemic Healthcare System” during the virtual conference DTx Europe on July 14th at 5:55 a.m. EST.